A prognostic Bayesian network that makes personalized predictions of poor prognostic outcome post resection of pancreatic ductal adenocarcinoma.
BACKGROUND:The narrative surrounding the management of potentially resectable pancreatic cancer is complex. Surgical resection is the only potentially curative treatment. However resection rates are low, the risk of operative morbidity and mortality are high, and survival outcomes remain poor. The a...
| Main Authors: | Alison Bradley, Robert Van der Meer, Colin J McKay |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0222270 |
Similar Items
-
A systematic review of methodological quality of model development studies predicting prognostic outcome for resectable pancreatic cancer
by: Alison Bradley, et al.
Published: (2019-08-01) -
Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
by: Wen-Jing Liu, et al.
Published: (2018-01-01) -
Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
by: Farzad Khalvati, et al.
Published: (2019-04-01) -
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
by: Lingyu Zhu, et al.
Published: (2023-08-01) -
Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma
by: Tomonari Shimagaki, et al.
Published: (2023-11-01)